Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

celltrion healthcare australia pty ltd - infliximab, quantity: 120 mg - injection, solution - excipient ingredients: acetic acid; sodium acetate trihydrate; sorbitol; polysorbate 80; water for injections - rheumatoid arthritis in adults remsima in combination with methotrexate, is indicated for the reduction of signs and symptoms and prevention of structural joint damage (erosions and joint space narrowing) in: - patients with active disease despite treatment with methotrexate - patients with active disease who have not previously received methotrexate.,remsima should be given in combination with methotrexate. efficacy and safety in rheumatoid arthritis have been demonstrated only in combination with methotrexate.,ankylosing spondylitis remsima is indicated for the reduction of signs and symptoms and improvement in physical function in patients with active disease.,psoriatic arthritis remsima is indicated for the treatment of the signs and symptoms, as well as for the improvement in physical function in adult patients with active and progressive psoriatic arthritis who have responded inadequately to disease-modifying anti-rheumatic drug (dmard) therapy. remsima may be administered in combination with methotrexate.,psoriasis remsima is indicated for the treatment of adult patients with moderate to severe plaque psoriasis for whom phototherapy or conventional systemic treatments have been inadequate or are inappropriate. safety and efficacy beyond 12 months have not been established.,crohn?s disease in adults remsima is indicated for the treatment of moderate to severe crohn?s disease, to reduce the signs and symptoms and to induce and maintain clinical remission in patients who have an inadequate response to conventional therapies.,refractory fistulising crohn?s disease remsima is indicated for reducing the number of draining enterocutaneous and rectovaginal fistulas and maintaining fistula closure in adult patients.,ulcerative colitis in adults remsimais indicated for the treatment of moderately severe to severe active ulcerative colitis in patients who have had an inadequate response to conventional therapy.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

celltrion healthcare australia pty ltd - infliximab, quantity: 120 mg - injection, solution - excipient ingredients: acetic acid; sodium acetate trihydrate; sorbitol; polysorbate 80; water for injections - rheumatoid arthritis in adults remsima in combination with methotrexate, is indicated for the reduction of signs and symptoms and prevention of structural joint damage (erosions and joint space narrowing) in: - patients with active disease despite treatment with methotrexate - patients with active disease who have not previously received methotrexate.,remsima should be given in combination with methotrexate. efficacy and safety in rheumatoid arthritis have been demonstrated only in combination with methotrexate.,ankylosing spondylitis remsima is indicated for the reduction of signs and symptoms and improvement in physical function in patients with active disease.,psoriatic arthritis remsima is indicated for the treatment of the signs and symptoms, as well as for the improvement in physical function in adult patients with active and progressive psoriatic arthritis who have responded inadequately to disease-modifying anti-rheumatic drug (dmard) therapy. remsima may be administered in combination with methotrexate.,psoriasis remsima is indicated for the treatment of adult patients with moderate to severe plaque psoriasis for whom phototherapy or conventional systemic treatments have been inadequate or are inappropriate. safety and efficacy beyond 12 months have not been established.,crohn?s disease in adults remsima is indicated for the treatment of moderate to severe crohn?s disease, to reduce the signs and symptoms and to induce and maintain clinical remission in patients who have an inadequate response to conventional therapies.,refractory fistulising crohn?s disease remsima is indicated for reducing the number of draining enterocutaneous and rectovaginal fistulas and maintaining fistula closure in adult patients.,ulcerative colitis in adults remsimais indicated for the treatment of moderately severe to severe active ulcerative colitis in patients who have had an inadequate response to conventional therapy.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - calcium carbonate, quantity: 350.059 mg (equivalent: calcium, qty 135.3 mg); calcium hydrogen phosphate, quantity: 224.178 mg (equivalent: calcium, qty 64.7 mg; equivalent: phosphorus, qty 50 mg); potassium sulfate, quantity: 182.868 mg (equivalent: potassium, qty 80 mg); dl-alpha-tocopheryl acetate, quantity: 115 mg (equivalent: dl-alpha-tocopherol, qty 50 mg); ascorbic acid, quantity: 90 mg; heavy magnesium oxide, quantity: 84.6 mg (equivalent: magnesium, qty 50 mg); cyanocobalamin, quantity: 22 microgram; betacarotene, quantity: 1.8 mg; nicotinamide, quantity: 15 mg; ferrous fumarate, quantity: 16.522 mg (equivalent: iron, qty 5 mg); calcium pantothenate, quantity: 14.862 mg (equivalent: pantothenic acid, qty 10 mg); manganese sulfate monohydrate, quantity: 10.875 mg (equivalent: manganese, qty 3.5 mg); zinc oxide, quantity: 9.432 mg (equivalent: zinc, qty 7.5 mg); colecalciferol, quantity: 15 microgram; pyridoxine hydrochloride, quantity: 7.095 mg (equivalent: pyridoxine, qty 5 mg); lycopene, quantity: 600 microgram; riboflavin, quantity: 3.2 mg; thiamine nitrate, quantity: 2.18 mg; cupric sulfate pentahydrate, quantity: 1.984 mg (equivalent: copper, qty 500 microgram); lutein, quantity: 500 microgram; folic acid, quantity: 400 microgram; potassium iodide, quantity: 0.2 mg (equivalent: iodine, qty 150 microgram); sodium selenite pentahydrate, quantity: 0.186 mg (equivalent: selenium, qty 55 microgram); chromic chloride hexahydrate, quantity: 0.183 mg (equivalent: chromium, qty 35 microgram); biotin, quantity: 45 microgram; phytomenadione, quantity: 25 microgram; retinol acetate, quantity: 2.737 mg (equivalent: vitamin a, qty 300 re) - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; colloidal anhydrous silica; hypromellose; titanium dioxide; glycerol; purified talc; iron oxide yellow; iron oxide black; iron oxide red; purified water; silicon dioxide; ethylcellulose; mannitol; dl-alpha-tocopherol; hydrogenated castor oil; butylated hydroxyanisole; butylated hydroxytoluene; starch sodium octenyl succinate; acacia; sucrose; maltodextrin; sodium ascorbate; maize oil; liquid glucose - antioxidant/reduce free radicals formed in the body ; helps enhance/promote collagen formation ; maintain/support collagen formation ; maintain/support energy levels ; helps convert (state food) into energy ; maintain/support body metabolism/metabolic rate ; maintain/support vitality ; maintain/support healthy eye function ; maintain/support eye health ; maintain/support healthy eyesight/vision ; maintain/support general health and wellbeing ; maintain/support hair health ; maintain/support gum health ; maintain/support healthy teeth ; maintain/support nail health/strength/thickness ; maintain/support bone health ; aids/assists healthy bone development/growth/building ; maintain/support (state mineral) absorption in bones ; helps enhance/promote bone mineralisation ; help maintain/support bone mineralisation ; vitamin d helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; aid/assist healthy red blood cell production ; maintain/support red blood cell health ; maintain/support blood health ; helps maintain/support transport of oxygen in the body ; aid/assist/helps oxygen transport to body tissues ; helps maintain/support haemoglobin formation/synthesis ; maintain/support heart health ; maintain/support immune system health ; helps enhance/improve/promote immune system function ; maintain/support healthy immune system function ; maintain/support muscle health ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral) within normal range ; maintain/support cognitive function/mental function ; maintain/support brain function ; maintain/support brain health ; maintain/support skin health

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

amgen australia pty ltd - 65413 - subcutaneous/intramuscular injection set, medicated - reconstitution procedure pack is a support pack for healthcare professionals and patients who need to reconstitute a powder for injection (not supplied with reconstitution pack) and then inject the reconstituted solution. it assists them by supplying aids and instructions for reconstituting medicines and injection.

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - fluroxypyr as the methyl heptyl ester; liquid hydrocarbon - emulsifiable concentrate - fluroxypyr as the methyl heptyl ester pyridine-pyridinoxy active 200.0 g/l; liquid hydrocarbon solvent other 502.0 g/l - herbicide

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - hydroxocobalamin chloride, quantity: 1.027 mg - injection, solution - excipient ingredients: water for injections; acetic acid; sodium chloride - the approved indications for hydroxocobalamin injection are for prophylaxis and treatment of pernicious (addisonian) anaemia and other macrocytic anaemias associated with vitamin b12 deficiency. treatment of optic neuropathies such as tobacco amblyopia and leber's optic atrophy.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

fair-med healthcare australia pty ltd - bisoprolol fumarate -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

fair-med healthcare australia pty ltd - bisoprolol fumarate -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

fair-med healthcare australia pty ltd - bisoprolol fumarate -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - aciclovir -